Navigation Links
David H. Murdock Research Institute Taps Waters for Laboratory Technology
Date:10/15/2008

Strategic Partnership Provides Advanced Technology for Groundbreaking

Nutrition and Disease Research

KANNAPOLIS, N.C. and MILFORD, Mass., Oct. 15 /PRNewswire-FirstCall/ -- The David H. Murdock Research Institute (DHMRI), located at the North Carolina Research Campus in Kannapolis, NC, and Waters Corporation (NYSE: WAT) announced today that Waters(R) has been selected as the institute's primary supplier of analytical science solutions, including mass spectrometers, liquid chromatographs and associated scientific data management software.

"We selected Waters as a partner based on their breakthrough technologies and hands-on approach to customer service. The equipment that we've purchased from Waters is recognized as the most sophisticated laboratory equipment available," said David H. Murdock, DHMRI founder. "This large purchase continues the momentum we're building as a cutting-edge research facility sought after by some of the nation's brightest scientists, and positions us well for the future."

The new laboratory instrumentation will enable DHMRI's research programs in the areas of nutrition science and disease prevention and provide state-of the-art capabilities in proteomics research and metabolic profiling, among other key application areas

"Our respective organizations have a similar focus on pushing the limits of scientific discovery and productivity, as well as collaboration," said Art Caputo, Executive Vice President and President of the Waters Division. "As with all our partners, we are pleased to be working closely with DHMRI to help make scientific discovery at the facility possible."

Among the new mass spectrometers purchased by DHMRI are a number of Waters(R) SYNAPT(TM) High Definition Mass Spectrometers -- the first commercially-available mass spectrometer with the ability to analyze ions by their size, shape and charge in addition to mass -- as well as the Waters Quattro Premier(TM) XE and ACQUITY(R) SQD systems. DHMRI also purchased several ACQUITY UltraPerformance liquid chromatography (UPLC(R)) systems as their preferred inlet to the Institute's mass spectrometers.

About the David H. Murdock Research Institute

The David H. Murdock Research Institute was established as a public charity to support groundbreaking research at the North Carolina Research Campus. Funded through a private grant by David H. Murdock, DHMRI will host the world's top talent and resources - and promote a level of scientific collaboration never before possible. DHMRI is the first of its kind, housing a unique collection of state-of-the-art instrumentation in one central location.

For more information visit http://www.dhmri.org.

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

For more information visit http://www.waters.com.

Waters, ACQUITY, UPLC, Synapt, and Quattro Premier XE are trademarks of Waters Corporation.

Contact:

Waters Corporation:

Brian J. Murphy

508-482-2614

Brian_J_Murphy@waters.com

DHMRI:

Phyllis Beaver

704-273-1181

pbeaver@castlecooke.com


'/>"/>
SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
5. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Immunosyn Corporation Names G. David Criner as CFO
8. Pasteuria Bioscience Taps New CEO David N. Duncan
9. David Mott Appointed Non Executive Director at Shire
10. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
11. Transgenomic Appoints David Pauluzzi to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... KCAS Bioanalytical and ... 0.2 ng/mL lower limit (LLOQ) assay for nicotine and two key metabolites cotinine ... ultra-low trace nicotine assay meets additional needs of tobacco industry that need to ...
(Date:4/27/2017)... MD (PRWEB) , ... April 27, 2017 , ... ... (CAI) and a winner of the 43North Startup Competition, has truly taken their ... Cygnus spacecraft delivered Oncolinx’s innovative cancer experiments from Cape Canaveral to the International ...
(Date:4/27/2017)... ... ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive results ... rare devastating genetic disease that leads to a sudden and rapid loss of central ... carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms more ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead Publishers is pleased to ... coming to San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, ... advances in the treatment of various types of pain. There are also extended ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):